Monthly weight-loss study for Chinese adults with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests an investigational medicine given once a month to help Chinese adults with overweight or obesity lose weight. It is a placebo-controlled trial, meaning some participants will receive a dummy injection, and the study will compare the effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- Your body mass index (BMI) is 28 or higher, or your BMI is between 24 and 28 and you have a weight-related health condition such as high blood pressure, high cholesterol, sleep apnea, heart disease, or type 2 diabetes.
- You have previously tried to lose weight through diet but were not successful.
- Your weight has been stable over the past 3 months (no change of more than 5%).
- You do not have a history of pancreatitis or certain thyroid conditions (medullary thyroid cancer or multiple endocrine neoplasia type 2), including in your family.
- If you are pregnant or breastfeeding, you cannot participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests a new once-monthly injection, berobenatide, to see if it is safe and helps adults with obesity lose weight. It is for people in Japan who have obesity and related health problems like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests a once-weekly injection called berobenatide to see if it helps adults with obesity lose weight and improve related health problems like high blood pressure, high cholesterol, or blood sugar issues. It is for people living in Japan.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.